HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 06, June 2017 – Advocacies in Support of Rare Disease Patients       » Bayer and NUS Enterprise Announce Winners of Grants4Apps? Singapore Open Innovation Challenge       » Cancer Control Efforts in Vietnam: Interview with Dr Tran Thanh Huong       » China Sets up National Lab Developing Brain-Like AI Technology       » New Womb-Like Invention for Preterm Infants       » World Asthma Day: Managing and Living with Asthma       » Managing Liver Cancer as a Global Health Problem      
EYE ON CHINA
NCKU stem cell research team discovers drug to rejuvenate aged hearts
A southern Taiwan-based National Cheng Kung University (NCKU) research team has identified the critical time period and a drug as treatment for cardiac repairing.

The stem cell research team led by Professor Patrick Ching-Ho Hsieh from the Institute of Clinical Medicine, NCKU, has discovered prostaglandin E2, a type of hormone-like medicine, capable of rejuvenating aged hearts.

The discovery sheds light on cardiac cell regeneration and provides another effective option for heart disease patients other than heart transplantation.

Hsieh said that cardiovascular disease such as congestive heart failure is a leading cause of morbidity and mortality throughout the world. Currently, there are about 6 million patients of congestive heart failure in the US and about 0.4 million patients in Taiwan.

In spite of intensive medical or surgical treatment, 80% of patients die within 8 years of diagnosis, Hsieh added.

He also noted that biomedical research nowadays has couple of milestones for heart diseases; however, the renewing mechanism is still unknown. It is also lacking a drug allowing stimulation of heart regeneration by endogenous stem cells.

After 7 years of work, Hsieh's team has identified the critical time period and the essential player for this cardiac repairing process.

Also a cardiovascular surgeon at the NCKU Hospital, Hsieh's research group used a special transgenic mouse model he developed when he was a research fellow at Harvard Medical School to investigate how endogenous stem cells regenerate cardiomyocytes following myocardial infarction, or heart attack.

They showed that the cardiac self-repairing process begins within 7 days after injury and it reaches its maximal activity on day 10.

The key player for this process is PGE2 and it is important for regulating cardiac stem cell activities. "More importantly, both young and old mice have significant improvements for cardiac repairing if you treat both of them PGE2," said Hsieh.

The NCKU research team figured out that PGE2 has the ability to lower the expression of the aging marker gene, transforming growth factor (TGF)-β1, and rejuvenates the micro-environment of the aged cells, Hsieh explained.

Source: Business Wire'

Click here for the complete issue.

NEWS CRUNCH  
news The Seventh International Meeting on Synthetic Biology (SB 7.0)
news Healthcare Sustainability in Asia: Now is the Time to Act — FT Asia Healthcare & Life Sciences Summit 2017
news Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy